ENVIRON International Corporation, Arlington, Virginia 22203, USA.
Toxicol Sci. 2013 Jan;131(1):1-8. doi: 10.1093/toxsci/kfs246. Epub 2012 Aug 8.
In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environmental Protection Agency that could both influence and be influenced by evolving toxicological practice. In particular, Science and Decisions emphasized the scientific and operational necessity of a new approach for dose-response modeling; addressed the recurring challenge of defaults in risk assessment and the question of when research results can be used in place of defaults; and reinforced the value of cumulative risk assessment, which would require enhanced understanding of the joint influence of chemical and nonchemical stressors on health outcomes. The objective of this article is to summarize key messages from Science and Decisions, both as a stand-alone report and in comparison with another recent NRC report, Toxicity Testing in the 21st Century: A Vision and a Strategy. Although these reports have many conclusions in common and reinforce similar themes, there are important differences that merit careful consideration, such as the move away from apical endpoints in Toxicity Testing and the emphasis on benefit-cost analyses and related decision tools in Science and Decisions that would be strengthened by quantification of apical endpoints. Moving risk assessment forward will require toxicologists to wrestle with the implications of Science and Decisions from a toxicological perspective.
2009 年,美国国家研究委员会(NRC)发布了一系列关于人类健康风险评估的咨询报告中的最新报告,题为《科学与决策:推进风险评估》。这份内容广泛的报告提出了一些与美国环境保护署风险评估实践相关的建议,这些建议既可能受到不断发展的毒理学实践的影响,也可能对其产生影响。特别是,《科学与决策》强调了建立新的剂量-反应模型方法的科学和操作必要性;解决了风险评估中默认值的反复出现的挑战以及何时可以使用研究结果代替默认值的问题;并强化了累积风险评估的价值,这将需要加强对化学和非化学应激因素对健康结果的联合影响的理解。本文的目的是总结《科学与决策》的主要信息,既作为一份独立的报告,也与美国国家研究委员会的另一项最新报告《21 世纪的毒理学测试:愿景与策略》进行比较。尽管这些报告有许多共同的结论,并强化了类似的主题,但也存在一些值得仔细考虑的重要差异,例如《毒性测试》中逐渐远离顶点终点,以及《科学与决策》中强调的成本效益分析和相关决策工具,这些都将通过量化顶点终点得到加强。推进风险评估将需要毒理学家从毒理学角度来应对《科学与决策》所带来的影响。